Gufic Biosciences Ltd.

GUFICBIO NSE Healthcare Pharmaceuticals
₹426.00
+0.79%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Moderate debt: debt-to-equity of 0.61.
  • Comfortable interest cover: operating profit covers interest about 4.1 times.
  • Return on equity is moderate at 10.1%.
  • Return on capital employed is moderate at 12.3%.
  • Net profit margin is 6.8%.
  • Pays a dividend (yield about 0.02%).
  • Has paid a dividend in each of the last 3 years on record.
  • Promoters hold a majority stake (72.5%).

!Watch-points

No notable watch-points flagged by the automated checks.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
3.66

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreWeak
3 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 4,272 Cr
Current Price₹ 426.00
High / Low₹ 467.80 / 268.00
Stock P/E58.276333
Book Value₹ 66.30
Dividend Yield0%
ROCE12.30%
ROE10.10%
Face Value₹ 1.00
Debt to Equity0.61
PEG Ratio
EV / EBITDA25.65
Industry PE35.70
P/B Ratio6.4245644
EPS₹ 6.40
Debt₹ 405 Cr
PAT Margin6.78%
Cash PAT₹ 95 Cr
ICR4.08
Promoter Holding72.50%
FII Holding0.47%
DII Holding3.67%
Public Holding23.36%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years
5 Years
3 Years
TTM 17.00%
Compounded Profit Growth
10 Years
5 Years
3 Years
TTM 19.00%
Stock Price CAGR
10 Years 27.00%
5 Years 17.00%
3 Years 13.00%
1 Year 15.00%
Return on Equity
10 Years
5 Years
3 Years 13.00%
Last Year 10.00%
Educational data only. Not a recommendation to buy, sell or hold any security.